Strengthening the HIV prevention continuum using pharmacies

利用药房加强艾滋病毒预防连续性

基本信息

  • 批准号:
    10619854
  • 负责人:
  • 金额:
    $ 78.59万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-06-01 至 2028-04-30
  • 项目状态:
    未结题

项目摘要

ABSTRACT Early HIV diagnosis is an essential component of the strategy to End the HIV Epidemic (EHE). Yet, half of the nearly 40,000 Americans who test positive for HIV every year have late (stage 3 AIDS) infection, which results in higher community transmission and poorer treatment outcomes. In the United States South, where HIV is disproportionately impacted, 50% of HIV infections are undiagnosed. Infrequent or delayed HIV testing is most often due to poor healthcare access and stigmatizing attitudes about HIV that inhibit prevention and treatment seeking. Thus, increased HIV testing access and uptake is urgently needed to normalize HIV testing and direct individuals to pre-exposure prophylaxis (PrEP) if they test HIV negative or HIV treatment if they test HIV positive. To increase HIV testing access and uptake, we propose integrating HIV prevention services within community pharmacies located in neighborhoods with high HIV prevalence. Despite promising evidence of feasibility of pharmacy-based HIV testing, it is not widely available. In fact, most local pharmacy boards lack policy guidance on HIV testing being within their scope of practice. Our work has shown that HIV testing uptake in community pharmacies can be increased if it is offered with less stigmatized non-HIV-related services (e.g., COVID19, blood pressure, glucose, and cholesterol screening). But many community pharmacy staff report inadequate training as barriers to integrating HIV testing into the pharmacy work system. Therefore, to evaluate the implementation and effectiveness of HIV testing and prevention services within community pharmacies we propose a hybrid type 1 study design that aims to 1) Examine the policy-, pharmacy staff- and client-level barriers and facilitators of adopting HIV prevention services (e.g., HIV testing, PrEP referral, HIV treatment referral) in community pharmacies, 2) Develop and implement pharmacy staff HIV prevention service (e.g., HIV testing and counseling, PrEP referral, HIV treatment referral) trainings, and 3) Test the effects of integrating HIV prevention services in community pharmacies with existing non-HIV-related screenings versus those without on effectiveness and implementation outcomes. Guided by the Exploration, Preparation, Implementation, Sustainment framework, this study will include an exploration phase that examines the barriers and facilitators to pharmacy-based HIV prevention service provision across the US South using online surveys of community pharmacy staff (n=300), and in-depth interviews of Board of pharmacy members (n=16) and pharmacy staff (n=40). In the preparation phase, a virtual community pharmacy HIV prevention training will be developed and offered to 150 community pharmacy staff. Finally, in the implementation and sustainment phase, we will evaluate the acceptability and sustainment of the HIV prevention service delivery over 12 months in 10 community pharmacies (5 pharmacies who offer primary prevention screenings vs. 5 pharmacies who do not). Findings will be used to support scaling HIV prevention services in community pharmacies in the South where efforts to reduce HIV transmission are desperately needed to EHE.
摘要 早期艾滋病毒诊断是结束艾滋病毒流行战略的重要组成部分。然而, 每年有近40,000名艾滋病毒检测呈阳性的美国人患有晚期(3期艾滋病)感染, 社区传播率较高,治疗效果较差。在美国南部, 50%的艾滋病毒感染者没有得到诊断。艾滋病毒检测不频繁或延迟是最常见的原因。 这通常是由于医疗保健条件差以及对艾滋病毒的污名化态度阻碍了预防和治疗 寻找因此,迫切需要增加艾滋病毒检测的获得和接受,以使艾滋病毒检测正常化, 暴露前预防(PrEP),如果他们测试HIV阴性或HIV治疗,如果他们测试HIV 肯定的:第为了增加艾滋病毒检测的获得和接受,我们建议整合艾滋病毒预防服务, 在艾滋病高发区的社区药店里。尽管有希望 虽然没有证据表明基于药物的艾滋病毒检测的可行性,但这种方法并不普遍。事实上,大多数当地药店 董事会缺乏关于艾滋病毒检测在其业务范围内的政策指导。我们的研究表明, 如果社区药房提供的非艾滋病毒相关的污名较少, 服务(例如,COVID 19、血压、血糖和胆固醇筛查)。但许多社区药房 工作人员报告说,培训不足是将艾滋病毒检测纳入药房工作系统的障碍。因此,我们认为, 评估社区内艾滋病毒检测和预防服务的实施情况和成效 我们提出了一个混合型1研究设计,旨在1)检查政策-,药房工作人员-和 采用艾滋病毒预防服务的客户层面障碍和促进因素(例如,HIV检测、PrEP转诊、HIV 治疗转诊),2)发展和实施药房工作人员艾滋病毒预防服务 (e.g.,艾滋病毒检测和咨询、PrEP转介、艾滋病毒治疗转介)培训,以及3)测试 将社区药房的艾滋病毒预防服务与现有的非艾滋病毒相关筛查相结合, 而那些没有关于有效性和执行结果的建议。以探索、准备、 实施,可持续框架,这项研究将包括一个探索阶段,审查 在美国南部使用在线提供基于药物的艾滋病预防服务的障碍和促进因素 对社区药房工作人员(n=300)进行调查,并对药房委员会成员(n=16)进行深入访谈 和药房工作人员(n=40)。在准备阶段,虚拟社区药房开展了艾滋病预防培训 将开发并提供给150名社区药房工作人员。最后,在执行和 在维持阶段,我们将评估艾滋病毒预防服务的可接受性和可持续性 在10个社区药房(5个药房提供初级预防筛查,5个药房提供初级预防筛查) 药店不做)。调查结果将用于支持扩大社区艾滋病毒预防服务 在南部,迫切需要努力减少艾滋病毒传播的药店。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NATALIE D. CRAWFORD其他文献

NATALIE D. CRAWFORD的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NATALIE D. CRAWFORD', 18)}}的其他基金

Advancing PrEP in pharmacies COVID supplement
推进药房的 PrEP 新冠肺炎补充剂
  • 批准号:
    10656788
  • 财政年份:
    2023
  • 资助金额:
    $ 78.59万
  • 项目类别:
Advancing pre-exposure prophylaxis (PrEP) access in pharmacies to improve PrEP uptake in disadvantaged areas
推动药房提供暴露前预防 (PrEP),以提高贫困地区的暴露前预防 (PrEP) 利用率
  • 批准号:
    10215269
  • 财政年份:
    2019
  • 资助金额:
    $ 78.59万
  • 项目类别:

相似海外基金

Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
  • 批准号:
    24K16488
  • 财政年份:
    2024
  • 资助金额:
    $ 78.59万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Mighty Accounting - Accountancy Automation for 1-person limited companies.
Mighty Accounting - 1 人有限公司的会计自动化。
  • 批准号:
    10100360
  • 财政年份:
    2024
  • 资助金额:
    $ 78.59万
  • 项目类别:
    Collaborative R&D
Accounting for the Fall of Silver? Western exchange banking practice, 1870-1910
白银下跌的原因是什么?
  • 批准号:
    24K04974
  • 财政年份:
    2024
  • 资助金额:
    $ 78.59万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A New Direction in Accounting Education for IT Human Resources
IT人力资源会计教育的新方向
  • 批准号:
    23K01686
  • 财政年份:
    2023
  • 资助金额:
    $ 78.59万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
An empirical and theoretical study of the double-accounting system in 19th-century American and British public utility companies
19世纪美国和英国公用事业公司双重会计制度的实证和理论研究
  • 批准号:
    23K01692
  • 财政年份:
    2023
  • 资助金额:
    $ 78.59万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
An Empirical Analysis of the Value Effect: An Accounting Viewpoint
价值效应的实证分析:会计观点
  • 批准号:
    23K01695
  • 财政年份:
    2023
  • 资助金额:
    $ 78.59万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Accounting model for improving performance on the health and productivity management
提高健康和生产力管理绩效的会计模型
  • 批准号:
    23K01713
  • 财政年份:
    2023
  • 资助金额:
    $ 78.59万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
CPS: Medium: Making Every Drop Count: Accounting for Spatiotemporal Variability of Water Needs for Proactive Scheduling of Variable Rate Irrigation Systems
CPS:中:让每一滴水都发挥作用:考虑用水需求的时空变化,主动调度可变速率灌溉系统
  • 批准号:
    2312319
  • 财政年份:
    2023
  • 资助金额:
    $ 78.59万
  • 项目类别:
    Standard Grant
New Role of Not-for-Profit Entities and Their Accounting Standards to Be Unified
非营利实体的新角色及其会计准则将统一
  • 批准号:
    23K01715
  • 财政年份:
    2023
  • 资助金额:
    $ 78.59万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Improving Age- and Cause-Specific Under-Five Mortality Rates (ACSU5MR) by Systematically Accounting Measurement Errors to Inform Child Survival Decision Making in Low Income Countries
通过系统地核算测量误差来改善特定年龄和特定原因的五岁以下死亡率 (ACSU5MR),为低收入国家的儿童生存决策提供信息
  • 批准号:
    10585388
  • 财政年份:
    2023
  • 资助金额:
    $ 78.59万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了